Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Review

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis

      
Total article views   HTML views PDF downloads Totals
14,647 Dovepress* 14,647+ 3,383 18,030
Totals 14,647 3,383 18,030
*Since 12 April 2010
+Since July 2016

View citations on Google Scholar